44. Use the PDR® to find another product name for each drug in the Representative Drugs table on pages 395–396.
Representative Hormones and Hormonelike Drugsa
Category, Nameb, Route | Uses and Diseases | Actions | Usual Dosec and Special Instructions | Side Effects and Adverse Reactions | |||
Hormones | |||||||
Levothyroxine sodium(Synthroid, Levothroid, Cytomel, Thyrolar) Oral | Hypothyroid conditions such as cretinism, myxedema, goiter, mild hypothy-roidism, surgical removal of thyroid gland | Is a synthetic thyroid hormone replacement; stimulates metabolism | Maintenance: 25–100 mcg po daily in single dose, increase by 50–100 mcg po every 1 to 4 weeks until desired response occurs | Headache, palpitations, sleeplessness, weight loss, nervousness, tachycardia, hypertension | |||
Glucagon Subcutaneous, IM, IV | Severe insulin reaction; hypoglycemia | Raises blood sugar by stimulating liver to convert glycogen to glucose | 0.5-1 mg; may be repeated 1 or 2 times as ordered | Nausea, vomiting, rash, dizziness | |||
Vasopressin tannate (Pitressin) Subcutaneous, IM | Diabetes insipidus | Replaces ADH of pituitary, promotes reabsorption of water in kidneys | 5–10 units IM or subcut, 2–3 times a day | Tremor, dizziness, headache, bradycardia, abdominal cramps, nausea, vomiting | |||
Somatropin (Humatrope) Subcutaneous, IM | Growth failure due to growth hormone deficiency | Stimulates growth | Up to 0.06 mg/kg subcut, or IM 3 times a week with minimum 48 hours between doses | Pain at site of injection, headache, localized muscle pain, weakness, intolerance to cold, weight gain, dry skin and hair | |||
Corticosteroids | |||||||
Fluticasone(Flonase) Aerosol, topical | Asthma Dermatitis | Suppresses inflammation and immune response | 88–440 mcg bid Apply cream sparingly to affected area 2–4 times daily | Epistaxis, nasal burning, pharyngitis, irritation of nasal mucous membranes, sneezing, runny nose, nasal dryness, nasal congestion, headache, dizziness, urticaria | |||
Prednisone(Deltasone) Oral | Hormone replacement, inflammatory diseases (e.g., arthritis, dermatitis), lymphatic cancer, allergies, ulcerative colitis, kidney disease | Suppresses inflammation and immune response, stimulates bone marrow, influences protein, fat, and carbohydrate metabolism | 2.5–15 mg po 2, 3, or 4 times a day, depending on specific disease, adjusted to lowest effective maintenance level; never abruptly discontinue drug; maintenance dose may be given daily or every other day | Euphoria, insomnia, edema, hypokalemia, GI upset (peptic ulcer), rounded (moon) face, delayed wound healing, weight gain, muscle weakness | |||
Dexamethasone (Decadron) Oral, I V, IM | Hormone replacement, inflammatory diseases (e.g., arthritis, dermatitis), lymphatic cancer, allergies, ulcerative colitis, kidney disease, cerebral edema | Suppresses inflammation and immune response; stimulates bone marrow; influences protein, fat, and carbohydrate metabolism | 0.25–4 mg po 2, 3, or 4 times a day depending on specific disease; never abruptly discontinue | Euphoria, insomnia, edema, hypokalemia, GI upset (peptic ulcer), rounded (moon) face, delayed wound healing, weight gain, muscle weakness | |||
Oral Hypoglycemics | |||||||
Metformin(Glucophage) Oral | Type 2 diabetes mellitus (NIDDM) | Stimulates release of insulin from beta cells in islets of Langerhans in pancreas | 500 mg bid; one with the morning and one with the evening meal; 850 mg daily with the morning meal; 500 mg XR daily with the evening meal; 1,000 mg XR daily with the evening meal | Diarrhea, nausea, vomiting, abdominal bloating, lightheadedness, headache, asthenia, rash | |||
Glyburide (DiaBeta, Micronase) Oral | Type 2 diabetes mellitus (NIDDM) | Stimulates release of insulin from beta cells in islets of Langerhans in pancreas | 2.5–5 mg po daily with breakfast | Nausea, vomiting, abdominal discomfort, f latulence, anorexia, diarrhea or constipation |
aSee also the hormones listed in Table 15.1.
bTrade names given in parentheses are examples only. Check current drug references for a complete listing of available products.
cAverage adult doses are given. However, dosages are determined by a physician and vary with the purpose of the therapy and the particular patient. The doses presented in this text are for general information only.
Answers will vary depending on the edition of the PDR® used.